Comparing Two Medicines for Overactive Bladder
Treatments studied
Part of Kidney & urinary, Women’s health & pregnancy clinical trials.
This study compares two pills (solifenacin and mirabegron) for treating overactive bladder. It aims to see which works better and has fewer side effects. You may qualify if you're newly diagnosed and haven't tried these medicines before.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are an adult (18 or older) with overactive bladder (sudden, strong urges to urinate).
- You have never taken prescription medicine for overactive bladder before.
- You can fill out a simple bladder diary and a symptom questionnaire.
- You do not have a bladder problem caused by a nerve or spinal cord condition.
- You have not had pelvic radiation, bladder cancer, or surgery on your bladder or prostate.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two medications—tadalafil (a daily pill for blood flow) and solifenacin (a pill that relaxes the bladder)—to see which works better for women with overactive bladder (OAB), which causes sudden, strong urges to urinate. It will help doctors find a treatment that may have fewer side effects.
This trial compares a new treatment (low-intensity shockwave therapy) with a standard medication (solifenacin) to see which works better for women with overactive bladder (OAB). Overactive bladder means you feel a sudden, strong need to urinate, often have to go frequently, or may leak urine. The study aims to find a more effective or better-tolerated option.
This study compares different treatments for overactive bladder in women in Taiwan. It aims to find the best approach to help control symptoms like frequent or urgent urination.
This trial tests whether simple blood tests can predict how well a woman with overactive bladder will respond to the medication mirabegron (also called Myrbetriq). If successful, doctors may be able to choose the right treatment earlier.
This study tests a new bladder treatment called NT 201 combined with a device called the Vibe System for women with overactive bladder (frequent, urgent need to urinate). The treatment is injected directly into the bladder and may help reduce urgency and leaking.
This study compares two treatments for overactive bladder (OAB): a nerve stimulation therapy (peroneal neuromodulation) versus pelvic floor exercises. It aims to see which is more effective in reducing urgent, frequent urination.
Hear when a new Overactive Bladder (OAB) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.